Company intelligence / Profile preview

Luco Hybrid OSA Appliance

Ownership: Private
Development stage: Other

Overview

The Luco Hybrid OSA Appliance is an FDA-cleared oral appliance indicated for the treatment of primary snoring and mild to moderate obstructive sleep apnea in adults. It is also cleared for treating sleep bruxism and as an aid in managing associated tension/migraine-type headaches. Clinical studies have shown it to be effective in reducing symptoms of both sleep-disordered breathing and bruxism.

Therapeutic areas: PulmonologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Therapeutic Medical Devices

Beyond the preview

Go deeper on Luco Hybrid OSA Appliance.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luco Hybrid OSA Appliance.

Explore the full profile